The proportion of different BCR-ABL1 transcript types in chronic myeloid leukemia. An international overview

Autor: Baccarani, Michele Castagnetti, Fausto Gugliotta, Gabriele and Rosti, Gianantonio Soverini, Simona Albeer, Ali Pfirrmann, Markus Bekadja, Mohamed-Amine Entasoltan, Badra Nachi, Mourad Elghandour, Ashraf El Sorady, Manal Abdelfattah, Raafat El Nahass, Yasser Samra, Mohamed Azzazi, Mohammed and Elsobki, Ezat Moussa, Mohamed Fahmy, Omar Mattar, Mervat and Shehata, Samir Eid Azmy, Emad Bolarinwa, Rahman A. Eid, Samir Khelif, Abderrhaim Hached, Farhat Menif, Samia and Rahman, Hafizur Huang, Xiaojun Jiang, Qian Ye, Yuanxin and Zhu, Huanling Chen, Suning Varma, Neelam Ganesan, Prasanth and Gundeti, Sadashivudu Malhotra, Hemant Radhakrishnan, Vivek S. Kumar, Lalit Sharawat, Surender Kumar Seth, Tulika and Ausekar, B. V. Balasubramanian, Poonkuzhali Poopak, Behzad and Inokuchi, Koiti Kim, Dong-Wook Al Kindi, Salam Mirasol, Angelina Qari, Mohammed Goh, Yeow Tee Shih, Lee-Yung and Branford, Susan Lion, Thomas Valent, Peter Burgstaller, Sonja Thaler, Joseph Labar, Boris Zadro, Renata Mayer, Jiri Zackova, Daniela Faber, Edgar Pallisgaard, Niels and Xavier-Mahon, Francois Lippert, Eric Cayuela, Jean Michel and Rea, Delphine Millot, Frederic Suttorp, Meinolf Hochhaus, Andreas Niederwieser, Dietger Saussele, Susanne Haferlach, Torsten Jeromine, Sabine Panayiotidis, Panayiotis Conneally, Eibhlin Langabeer, Steve Nagler, Arnon Rupoli, Serena and Santoro, Nicola Albano, Francesco Castagnetti, Fausto and Ottaviani, Emanuela Rambaldi, Alessandro Stagno, Fabio and Molica, Stefano Biagiotti, Caterina Scappini, Barbara and Lemoli, Roberto Iurlo, Alessandra Pungolino, Ester Menna, Giuseppe Pane, Fabrizio Gottardi, Enrico Rege-Cambrin, Giovanna Binotto, Gianni Putti, Maria Caterina Falzetti, Franca Visani, Giuseppe Galimberti, Sara Musto, Pellegrino and Abruzzese, Elisabetta Breccia, Massimo Giona, Fiorina and Chiusolo, Patrizia Sica, Simona Fava, Carmen Ferrero, Dario and Tiribelli, Mario Bonifacio, Massimiliano Griskevicius, Laimonas Musteata, Vasile Janssen, Jeroen Prejzner, Witold and Sacha, Tomasz Waclaw, Joanna Almeida, Antonio Medina and Kulikov, Sergei Turkina, Anna Bogdanovic, Andrija Zupan, Irena Marce, Silvia Cervantes, Francisco Steegmann, Juan Luis Kotlyarchuk, Konstyantyn Milner, Benedict J. Rose, Susan Clench, Tim Waits, Paula Austin, Steve Wickham, Caroline Clark, Richard Apperley, Jane Claudiani, Simone and Foroni, Letizia Szydlo, Richard Burt, Emma Bescoby, Ruth and Cork, Leanne O'Brien, Stephen Green, Bethaney Hawtree, Sarah and Watson, Mark Bengio, Raquel Maria Larripa, Irene and Pavlovsky, Carolina Moiraghi, Beatriz Requiao de Pinna, Cristiane Almeida Romani Magalhaes, Gustavo Henrique Pagnano, Katia Funke, Vaneuza Tavares, Renato Sampaio Prado, Adriana and Azevedo, Alita Andrade Fogliatto, Laura Bonecker, Simone and Centrone, Renato Moellman, Artur Conchon, Monika Centurion, Maria Elida Prado, Ana-Ines Lopez, J. L. Petruzziello, Fara and Bendit, Israel Int BCR-ABL Study Grp

There are different BCR-ABL1 fusion genes that are translated into proteins that are different from each other, yet all leukemogenic, causing chronic myeloid leukemia (CML) or acute lymphoblastic leukemia. Their frequency has never been systematicall

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2127::baa3f46c05fe505da92ba42d54f5789b
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3183798

Predictive Value of Pretreatment BCR-ABLIS Transcript level on Response to Imatinib Therapy in Egyptian Patients with Chronic Phase Chronic Myeloid Leukemia (CPCML)

Autor: El-Metnawy, Wafaa H., Mattar, Mervat M., El-Nahass, Yasser H., Samra, Mohamed A., Abdelhamid, Hala M., AbdlFattah, Raafat M., Hamed, Ahmad R.

Publikováno v: International Journal of Biomedical Science : IJBS

Background: A wide range of responses of patients with CPCML to IM has been reported. Several factors were proposed to predict response including molecular response at 3 and 6 months. Purpose: To study the impact of pretreatment BCR-ABL transcript le

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::8030dcbcf02b4b23490f35f145e1c920
http://europepmc.org/articles/PMC3644415

Second Report of Arab Leukemia Net (ALN) Registry for Chronic Myeloid Leukemia (CML) in the Middle East &North Africa Region (AFME). Epidemiology of CML and Additional Chromosomal Abnormalities (ACAs) in Egypt, Multicenter Results

Autor: Azzazi, Mohamed osman ^*, Fahmy, Omar, Mattar, Mervat ^*, El Ghandour, Ashraf ^*, El Sorady, Manal ^*, Shehata, Samir ^*, El Nahass, Yasser. ^*, Hegab, Hani ^*, Ibrahim, Rasha ^*, Magdy, Rasha ^*, Ellithy, Hend ^*, Shazly, Mohammad ^*, Khaled, Rana Hussein ^*, Sameir, Mai ^*, Elshaer, Mohab ^*

Publikováno v: In Blood 6 December 2014 124(21):5539-5539

High Frequency of ASXL1 and IDH Mutations in Young Acute Myeloid Leukemia Egyptian Patients.

Autor: El Nahass YH; National Cancer Institute, Cairo University, Egypt., Nader HA; Genome Onco-Center, Cairo, Egypt., Sabet S; Department of Zoology, Faculty of Science, Cairo University, Egypt., Nooh HA; National Cancer Institute, Cairo University, Egypt., Bassiony H; Department of Zoology, Faculty of Science, Cairo University, Egypt., Kamel M; National Cancer Institute, Cairo University, Egypt., Samra MA; National Cancer Institute, Cairo University, Egypt., Mahmoud HK; National Cancer Institute, Cairo University, Egypt., El Metnawy WH; Faculty of Medicine, Cairo University, Egypt., El Refaey FA; National Cancer Institute, Cairo University, Egypt.

Publikováno v: Asian Pacific journal of cancer prevention : APJCP [Asian Pac J Cancer Prev] 2022 Mar 01; Vol. 23 (3), pp. 977-984. Date of Electronic Publication: 2022 Mar 01.